Depot medroxyprogesterone acetate galactorrhea
Cromwell, P.; Anyan, W.
Journal of Adolescent Health Official Publication of the Society for Adolescent Medicine 23(2): 61
1998
ISSN/ISBN: 1054-139X PMID: 9714166 DOI: 10.1016/s1054-139x(97)00266-8Document Number: 276525
Document emailed within 0-6 h
Related Documents
Zia, Y.; Tang, J.H.; Chinula, L.; Tegha, G.; Stanczyk, F.Z.; Kourtis, A.P. 2019: Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi Contraception 100(5): 402-405Sturm, G.; Antal, E.; Schmidt Rhode, P.; Bauer, T.; Schulz K D. 1986: Medroxyprogesterone acetate and immunoreactive medroxyprogesterone acetate metabolites measured by two different selective radioimmunoassay antibodies in medroxyprogesterone acetate treated breast cancer patients Anticancer Research 6(3 Part A): 362
Bonhomme, M.G.; Potts, D.M.; Fortney, J.A.; Allen, M.Y. 1991: Safety of depot medroxyprogesterone acetate Lancet 338(8772): 942
Bakry, S.; Merhi, Z.O.; Scalise, T.J.; Mahmoud, M.S.; Fadiel, A.; Naftolin, F. 2008: Depot-medroxyprogesterone acetate: an update Archives of Gynecology and Obstetrics 278(1): 1-12
Mishell, D.R. 1996: Pharmacokinetics of depot medroxyprogesterone acetate contraception Journal of Reproductive Medicine 41(5 Suppl): 381-390
Cullins, V.E. 1996: Noncontraceptive benefits and therapeutic uses of depot medroxyprogesterone acetate Journal of Reproductive Medicine 41(5 Suppl): 428-433
Kaunitz, A.M.; Grimes, D.A. 2011: Removing the black box warning for depot medroxyprogesterone acetate Contraception 84(3): 212-213
Lumbiganon, P. 1994: Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary Contraception 49(3): 203-209
Atrio, J. 2015: Accounting for anovulation and vaginal thinning during depot medroxyprogesterone acetate use Journal of Infectious Diseases 211(5): 850
Guirguis-Blake, J. 2011: Copper intrauterine device vs. depot medroxyprogesterone acetate for contraception American Family Physician 83(1): 35-36
Sathyamala, C.; Shah, P.; Jain, Y.; Bhargava, A. 1994: Use of injectable depot medroxyprogesterone acetate in lactating Indian women Lancet 344(8915): 134-135
Sathyamala, C.; Shah, P.; Jain, Y.; Bhargava, A. 1994: Use of injectable depot medroxyprogesterone acetate in lactating Indian women Lancet 344(8915): 134-135
Arowojolu, A.O. 2000: Treatment of endometriosis with depot medroxyprogesterone acetate: a preliminary experience African Journal of Medicine and Medical Sciences 29(1): 55-58
Frederiksen, M.C. 1996: Depot medroxyprogesterone acetate contraception in women with medical problems Journal of Reproductive Medicine 41(5 Suppl): 414-418
Lumbiganon, P. 1994: Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary Contraception 49(3): 203-209
Bloch, B. 1971: Depot medroxyprogesterone acetate (Depo-Provera) as a contraceptive preparation South African Medical Journal 45(28): 777-780
Sathyamala, C.; Shah, P.; Jain, Y.; Bhargava, A. 1994: Use of injectable depot medroxyprogesterone acetate in lactating Indian women Lancet 344(8915): 134-135
Kaunitz, A.M. 1994: Long-acting injectable contraception with depot medroxyprogesterone acetate American Journal of Obstetrics and Gynecology 170(5 Pt 2): 1543-1549
Torok, M.R.; Miller, W.C.; Hobbs, M.M.; Macdonald, P.D.M.; Leone, P.A.; Schwebke, J.R.; Seña, A.C. 2009: The association between oral contraceptives, depot-medroxyprogesterone acetate, and trichomoniasis Sexually Transmitted Diseases 36(6): 336-340
2008: ACOG Committee Opinion No. 415: Depot medroxyprogesterone acetate and bone effects Obstetrics and Gynecology 112(3): 727-730